Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bondronat loading doses for bone pain in breast cancer
NCT00502736Phase 2Completed
- Sponsor
- Roche
- Start
- Jan 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibandronic acid in bone metastases, sponsored by Roche. Started Jan 2008; status: completed.
02
Drugs
ibandronic acid
03
Conditions
bone metastases
Beyond the preview
Go deeper on NCT00502736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00502736.